Cardiovascular
Immunology
Neurology
Muscle, Bone, Cartilage
Metabolic Diseases
Oncology
Respiratory
Pain Management
Rheumatoid Diseases
Eyes, ears, nose, throat
Psychiatric
Skin
Urology

Supportive therapy for anemia

Peripheral Arterial Occlusive Disease (PAOD)

Prevention of venous thrombo-embolism in hospitalized, medically ill patients; X-factor activator

Atrial Fibrillation / Class III antiarrythmica

Hypertension Endothelin Receptor Antagonist

Pulmonary Arterial hypertension

Pulmonary Arterial Hypertension Prostacyclin Receptor Agonist

ST-segment elevation myocardial Infarction / Antithrombotic drug

Unstable Angina / Non-ST-segment elevation myocardial Infarction / Antithrombotic drug

Non Small Cell Lung Cancer / Vaccine

Cardiovascular outcome study in patients with moderate to severe rheumatoid arthritis

Clostridium difficile Infection Antibiotic

Infective disease / Vaccine

Tick – borne encephalitis – Prophylaxis/Vaccination Virus Vaccine

Crohns Disease / TNF - ALPHA Inhibitor

Erosive Esophagitis / Proton Pump Inhibitor

Ulcerative colitis

Ankylosing Spondylitis /TNF - ALPHA Inhibitor

ADHS

Aneurysmal Subarachnoid Hemorrhage / Endothelin A Receptor Antagonist

Aneurysmal subarachnoid Hemorrhage with coiling; Endothelin receptor antagonist

Aneurysmal subarachnoid hemorrhage with surgical clipping; Endothelin receptor antagonist

MS Fumarate

MS S1P1 Receptor Agonist

Multiple Sclerosis

Neuropathic pain

Parkinson's Disease

Continuous sedation of patients in intensive care unit; sedatives

Primary Insomnia

Primary Insomnia / Orexin Receptor Antagonist

Stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics; GLYT1 - inhibitor

Duchene Muscle Dystrophy

Acid related disorders / Proton Pump Inhibitor

Abdominal Adiposity, Dyslipidemia CB1-receptor antagonist

Abdominal Obesity with Dyslipidemia / Acomplia

Acute lymphatic leukaemia

Chronic lymphatic leukaemia

Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia RTK Inhibitor

Cancer patients with opioid-induced

Primary Myelodysplastic Syndrome (MDS); secondary MDS and Chronic Myelomonocytic Leukemia

Breast cancer

Breast Cancer; monoclonal antibody

Colon cancer

Diffuse large B-cell non-Hodgkin’s Lymphoma / Aza-antracenedione

Pancreatic cancer

Non small cell lung cancer / chimerized antibody of IGG1 subclass

Renal Cell Carcinoma

Patients with stage IV Non-Small Lung Cancer; therapeutic vaccine

Interstitial pneumonia / Pulmonary Fibrosis / Neuromodulator

Pneumonia

PuPulmonary Fibrosis / Neuromodulator

Non Small Cell Lung Cancer / Vaccine

Pulmonary Fibrosis Vasoactive Intestinal Peptide

Pulmonary Sarcoidosis / Vasodilator

Smoking cessation MAO B-inhibitor

Non-cancer patients with opioid-induced constipation
Evaluation and safety study in patients with adult-onset active and progressive psoriatic arthritis (PSA)

Diabetic retinopathy

HLA-matching in corneal transplantation

Major depression

Patients with chronic idiopathic urticaria; Monoclonal antibody

Psoriasis vulgaris

Renal Impairment / Proton Pump Inhibitor